In July, we added 111 citations in DIDB, including 62 in vitro (with 13 articles published in July 2026) and 49 in vivo articles (with 36 articles published in July 2026).
3 NDAs and 1 BLA approved by the FDA from May to June in 2026, including cipeprofol (CYPSEDO), ensitrelvir (XOCOVA), sonrotoclax (BEQALZI), and veligrotug (LUMVOA) were also curated in DIDB.
You can check the citations that are recently published and entered in DIDB and all the NDAs/BLAs in DIDB.
As always, feel free to contact us if you have any questions or comments.